Key Highlights
- Marvell Technology announces Fiscal Q2 2027 results after Thursday’s closing bell, August 27
- Shares have skyrocketed 188% in 2027 so far, with positive post-earnings moves in 6 of the last 8 reports
- Consensus forecasts point to adjusted earnings per share of $0.93 on $2.72 billion in revenue
- The semiconductor firm recently landed a significant custom chip agreement with Alphabet, featuring warrants linked to potentially $120 billion in future orders
- Wall Street analysts maintain a Strong Buy rating with a consensus price target reaching $295.42
Marvell Technology is set to unveil its Fiscal Q2 2027 financial results following Thursday’s market close, coming just one day after NVIDIA’s exceptional quarterly performance reinforced optimism surrounding AI infrastructure investments.
Marvell Technology, Inc., MRVL
Trading around $242.86 before the earnings announcement, MRVL shares were down approximately 0.91% during the session. The semiconductor stock has delivered remarkable gains of 188% since the beginning of the year and climbed more than 217% over the trailing twelve months.
Analyst estimates call for adjusted earnings of $0.93 per share alongside revenue totaling $2.72 billion. The company’s track record shows it has exceeded earnings projections in 7 of its last 8 quarterly reports while meeting or surpassing revenue forecasts in all 8 periods.
NVIDIA’s Wednesday performance was impossible to overlook. The GPU giant announced revenue reaching $96.2 billion, featuring data center sales that surged 117% compared to the prior year. Management also provided forward guidance of $108 billion for the upcoming quarter, significantly exceeding analyst expectations.
This creates elevated expectations for Marvell’s report. The critical question investors face is whether AI infrastructure spending is expanding beyond GPUs into the networking, interconnect technologies, and custom chip solutions where Marvell competes.
The company’s data center division has experienced rapid expansion as cloud hyperscalers pour capital into network infrastructure upgrades. This particular segment will likely draw the most scrutiny from investors during Thursday’s announcement.
Alphabet Partnership Draws Attention
The most significant development in Marvell’s recent narrative centers on its custom silicon operations. The firm recently finalized an agreement with Alphabet that incorporated warrants connected to a staggering $120 billion in potential future orders.
This announcement sent shockwaves through the market, particularly affecting Broadcom, the established leader in custom AI silicon, whose shares plummeted over 10% following the news. For Marvell, the partnership represents meaningful validation that its custom chip strategy is generating substantial momentum.
Investors will pay close attention to any executive commentary regarding the company’s pipeline for additional custom chip partnerships during the earnings call.
Premium Pricing Offers Limited Cushion
Following a nearly 30% appreciation over just the past month, MRVL shares currently trade at approximately 84 times trailing twelve-month earnings and roughly 25 times sales. Such elevated multiples provide minimal tolerance for any guidance disappointment.
The current earnings season has demonstrated time and again that even solid quarterly results can spark sell-offs when forward guidance merely aligns with expectations. Marvell confronts this identical challenge.
Looking at historical patterns, the stock has demonstrated strength following earnings announcements. Shares have climbed in 6 of the previous 8 post-earnings trading sessions, including impressive rallies of 23% following the December 2024 release and 18% after the March 2026 report.
However, the two negative reactions saw substantial declines of 19.81% and 18.6%, illustrating the stock’s potential for volatility in both directions.
Based on coverage from 39 Wall Street analysts, Marvell carries a Moderate Buy consensus rating with an average price objective of $258.42, representing approximately 4% upside from current levels. The most optimistic analyst target stands at $400.
An alternate grouping of 27 analysts maintains a Strong Buy recommendation with an elevated average target of $295.42.
Thursday’s trading volume registered around 8 million shares, substantially below the three-month average daily volume of 37.71 million, indicating market participants are adopting a wait-and-see approach ahead of the earnings release.





